Pages that link to "Q37662627"

The following pages link to CTGF is a therapeutic target for metastatic melanoma. (Q37662627):

Displaying 30 items.

• CCN: core regulatory proteins in the microenvironment that affect the metastasis of hepatocellular carcinoma? (Q26779818) (← links)
• Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy (Q26784039) (← links)
• The emerging molecular machinery and therapeutic targets of metastasis (Q27022207) (← links)
• Gene Network Rewiring to Study Melanoma Stage Progression and Elements Essential for Driving Melanoma (Q28550898) (← links)
• Pentoxifylline Inhibits WNT Signalling in β-Cateninhigh Patient-Derived Melanoma Cell Populations (Q28552213) (← links)
• 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications (Q30239808) (← links)
• CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d (Q33977066) (← links)
• Structural ECM components in the premetastatic and metastatic niche (Q34521147) (← links)
• Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells. (Q35552019) (← links)
• Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis (Q36070956) (← links)
• CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer (Q36544662) (← links)
• IL-13 receptor α2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice (Q36545018) (← links)
• Tumor Autonomous Effects of Vitamin D Deficiency Promote Breast Cancer Metastasis. (Q36753868) (← links)
• Cuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondria (Q37148313) (← links)
• Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers. (Q37162642) (← links)
• Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions (Q38258015) (← links)
• Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease. (Q38259755) (← links)
• Targeting YAP in malignant pleural mesothelioma. (Q38704895) (← links)
• CCN2 Expression by Tumor Stroma Is Required for Melanoma Metastasis (Q38853759) (← links)
• High expression of connective tissue growth factor accelerates dissemination of leukaemia. (Q40068307) (← links)
• Exogenous growth factors bFGF, EGF and HGF do not influence viability and phenotype of V600EBRAF melanoma cells and their response to vemurafenib and trametinib in vitro (Q41501598) (← links)
• Transforming growth factor β1 regulates the expression of CCN2 in human keratinocytes via Smad-ERK signalling (Q41932459) (← links)
• Connective tissue growth factor and β-catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma (Q44443843) (← links)
• Fibroblasts potentiate melanoma cells in vitro invasiveness induced by UV-irradiated keratinocytes. (Q50051096) (← links)
• Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies (Q50104130) (← links)
• Vemurafenib and trametinib reduce expression of CTGF and IL-8 in V600EBRAF melanoma cells (Q50962170) (← links)
• Connective tissue growth factor-specific monoclonal antibody inhibits growth of malignant mesothelioma in an orthotopic mouse model. (Q52714599) (← links)
• The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity (Q57816901) (← links)
• Quantitative relationships between SMAD dynamics and target gene activation kinetics in single live cells (Q64105371) (← links)
• Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity (Q104568869) (← links)